Thyroid hormone resistance patient registry
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.
This study creates a registry for people with thyroid hormone resistance caused by specific genetic mutations. It helps doctors collect data to better understand and treat the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a mutation in the SLC16A2 or THRA gene.
- Your blood tests show an abnormal fT3/fT4 ratio.
- You or your caregiver agree to join the study.
- You have not withdrawn your consent or had your diagnosis changed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people with known or suspected thyroid problems to better understand how these conditions develop and behave. It doesn't test a new treatment, but it helps doctors learn more about thyroid disorders, which may improve care.
This trial is for people who may have a problem with how their body responds to thyroid hormone. It aims to better understand, diagnose, and monitor these conditions to improve care.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study builds a family registry to better understand inherited transthyretin (hATTR) amyloidosis in adults with a confirmed genetic mutation. It may help researchers learn more about the condition and plan future studies, and it requires follow-up visits.
This study looks at metabolic health in young children (ages 5 and up) who have permanent congenital hypothyroidism (a thyroid condition present from birth). The goal is to understand if these children have higher risks for conditions like obesity or diabetes, which may help doctors provide better care.
Hear when a new Hypothyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.